 |
Liposomal-cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane-Pt (II) |
|---|---|
| Trade Name | Aroplatin |
| Orphan Indication | Malignant mesothelioma |
| USA Market Approval | USA |
| USA Designation Date | 1999-09-01 00:00:00 |
| Sponsor | Antigenics Incorporated;3 Forbes Road;Lexington, Massachusetts, 02421 |
